Chondroectodermal dysplasia - what does this mean
Chondroectodermal dysplasia is an inherited disorder caused by a mutation in the eftud2 gene. it affects the development of bones, cartilage, and connective tissue, leading to short stature, abnormal growth of the ribs, and abnormalities of the fingers and toes. it is also associated with hearing loss, pulmonary valve stenosis, and other heart problems.
What happens during the disease - chondroectodermal dysplasia
Chondroectodermal dysplasia is a rare genetic disorder caused by a mutation in the eftud2 gene. this mutation affects the development of cartilage and bone, leading to skeletal abnormalities such as short stature, joint contractures, and malformations of the rib cage and vertebrae. it is also associated with abnormalities of the heart, eyes, and urinary system. the exact mechanism of the disease is still unknown, but it is thought to be caused by a defect in the synthesis of collagen and other proteins required for the development of cartilage and bone.
Treatment and Medical Assistance
Main goal of the treatment: To improve the physical and functional abilities of the patient with Chondroectodermal dysplasia.
- Physical therapy
- Occupational therapy
- Speech therapy
- Surgery to correct skeletal abnormalities
- Medications to control pain
- Assistive devices and orthotics
- Counseling and support
28 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Chondroectodermal dysplasia - Prevention
Prevention of chondroectodermal dysplasia is primarily achieved through genetic counseling and pre-natal testing. couples who have a family history of the disorder should seek genetic counseling to understand their risk of having a child with chondroectodermal dysplasia, and if necessary, pre-natal testing can be done to determine if the fetus is affected.